Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $128.4 million.

  • Phibro Animal Health's Accumulated Expenses rose 925.61% to $128.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $128.4 million, marking a year-over-year increase of 925.61%. This contributed to the annual value of $139.0 million for FY2025, which is 5658.1% up from last year.
  • Per Phibro Animal Health's latest filing, its Accumulated Expenses stood at $128.4 million for Q4 2025, which was up 925.61% from $121.1 million recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Accumulated Expenses peaked at $139.0 million during Q2 2025, and registered a low of $68.7 million during Q3 2022.
  • For the 5-year period, Phibro Animal Health's Accumulated Expenses averaged around $89.6 million, with its median value being $81.3 million (2022).
  • Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 1086.86% in 2021, then surged by 5658.1% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Accumulated Expenses stood at $72.8 million in 2021, then dropped by 1.62% to $71.7 million in 2022, then increased by 5.05% to $75.3 million in 2023, then soared by 56.16% to $117.6 million in 2024, then increased by 9.26% to $128.4 million in 2025.
  • Its Accumulated Expenses was $128.4 million in Q4 2025, compared to $121.1 million in Q3 2025 and $139.0 million in Q2 2025.